genotoxic impurities (4 of 4)
Published 10 years ago • 2.5K plays • Length 22:20Download video MP4
Download video MP3
Similar videos
-
21:53
selected case studies and impurity strategies for drug substances by paul wrezel, ph.d. (full)
-
9:58
process for qualifying impurities (3 of 4)
-
7:34
impurity assessment (2 of 4)
-
7:59
selected case studies and impurity strategies for drug substances part i: introduction to pgis
-
6:18
safety evaluation of impurities: introduction and overview (1 of 4)
-
16:01
avoiding potholes in process development part iv: safety testing for drug products
-
8:49
selected case studies and impurity strategies for drug substances part ii: case studies
-
6:04
selected case studies and impurity strategies for drug substances part iii: exercise & conclusion
-
13:52
analytical package, cmc and impurities (5 of 6)
-
2:21
gmps for pharmaceutical excipients - section 4 of 6
-
10:37
structure elucidation of impurities in drug substances by 2d nmr part v: conclusions and q&a
-
8:50
items to consider with your dmf (4 of 5)
-
10:32
genotoxic impurities guidance - institute of pharmaceutical management
-
3:03
technical chromatography resources from regis technologies
-
1:03:08
speeding drug development through impurity control strategies
-
1:01
regional innovative technology
-
1:01:39
success factors in your ind filing
-
49:27
analytical strategies from early development to validation